Cervical Edema Management
Initial Dosing and Treatment
- For cervical edema, dexamethasone 16 mg/day (4 mg four times daily) is the recommended initial dose, followed by tapering as clinical improvement occurs, as suggested by the American Thoracic Society 1
- Start steroids as soon as possible when inflammatory airway edema is suspected, and continue for at least 12-24 hours after clinical improvement begins, according to the American Society of Anesthesiologists 2
- Single-dose steroids immediately before extubation are ineffective, as stated by the American Society of Anesthesiologists 2
- Initial therapy for inflammatory conditions in pediatric patients is prednisone at 1-2 mg/kg daily (up to 60 mg daily), with tapering schedules varying based on clinical response, as supported by the American Academy of Pediatrics 3, 3
- The American College of Physicians recommends oral prednisone 20-40 mg daily as initial therapy, with a reduced starting dose for patients with comorbidities such as diabetes, psychosis, or osteoporosis 4
Steroid Tapering and Duration
- For short courses (5-10 days), taper by reducing dose by approximately 50% every 2-3 days, while for longer courses, reduce by 10 mg every 2 weeks until reaching 30 mg/day, then by 5 mg every 2 weeks until 20 mg/day, then by 2.5 mg every 2 weeks, although the specific guideline society is not mentioned in this context
- Always taper steroids after courses longer than 5-7 days to avoid abrupt discontinuation, as recommended by the American College of Physicians 5
- Tapering is essential for courses of oral steroids longer than 10 days to prevent adrenal suppression, with a gradual taper over 6 months after achieving remission 6, 7
- The taper schedule for prednisone involves reducing the dose by 10 mg every 2 weeks until reaching 30 mg/day, then by 5 mg every 2 weeks until reaching 20 mg/day, and finally by 2.5 mg every 2 weeks until completed, with the option to slow the reduction to 1 mg every 2-4 weeks at 10 mg/day, as outlined by the Mayo Clinic Proceedings 7
Monitoring and Adverse Effects
- Monitor for hyperglycemia, especially in diabetic patients, and watch for signs of gastrointestinal irritation or bleeding, as advised by the British Association of Dermatologists 5
- Assess for mood changes, insomnia, and increased appetite, and consider calcium and vitamin D supplementation for prolonged use (>3 weeks), as suggested by the British Association of Dermatologists 5
- Patients on oral steroids should be monitored for common adverse effects, including hyperglycemia, weight gain, mood changes, insomnia, and increased appetite 3
- Monitoring for hyperglycemia and weight gain is essential, as these are the most frequent adverse events associated with steroid treatment 8
- Long-term use of systemic corticosteroids is associated with a significant risk of developing related complications, according to the American Academy of Dermatology 9
Special Considerations
- Patients with poorly controlled diabetes may require more frequent glucose monitoring, and consider prophylactic proton pump inhibitors for patients with history of peptic ulcer disease, according to the American Gastroenterological Association, although not explicitly stated in this context
- For patients with severe edema causing airway compromise, consider adding nebulized adrenaline (1 mg), as recommended by the American Society of Anesthesiologists 2
- For iatrogenic macroglossia, high-dose oral prednisone at 0.5-1 mg/kg/day (typically 60-80 mg daily) for 7-14 days, followed by a gradual taper over 2-4 weeks depending on clinical response, is recommended by the Mayo Clinic Proceedings and the American Academy of Otolaryngology-Head and Neck Surgery 7, 8
- For severe macroglossia with potential airway compromise, initial IV methylprednisolone 1-2 mg/kg/day may be considered, with conversion to oral steroids when clinically improved, as recommended by the Journal of Clinical Oncology 10
- For patients with contraindications to systemic steroids, such as poorly controlled diabetes, intratympanic steroid injections may be considered as an alternative delivery method, using dexamethasone or methylprednisolone, according to the American Academy of Otolaryngology-Head and Neck Surgery 8
- For extensive bullous pemphigoid, a dose of 0.75-1.0 mg/kg/day is recommended, according to the British Association of Dermatologists and the British Journal of Dermatology 5, 11
- For pemphigus vulgaris, initial therapy with 1-2 mg/kg/day (commonly 1 mg/kg/day) is recommended, according to the British Journal of Dermatology 12
- For histoplasmosis with inflammatory manifestations, prednisone 0.5-1.0 mg/kg/day (maximum 80 mg) for 1-2 weeks with tapering is recommended, according to the Clinical Infectious Diseases 13
- For moderate to severe ulcerative colitis, prednisolone 40 mg daily, tapering over 6-8 weeks is recommended, according to the Gut journal 14
- For multisystem inflammatory syndrome in children (MIS-C), first-line IV methylprednisolone 1-2 mg/kg/day is recommended, according to the Arthritis and Rheumatology journal 15
- For major surgery, hydrocortisone 100 mg IV at induction, followed by a continuous infusion of 200 mg/24h, is recommended, with postoperative continuation of the infusion while NPO, then double oral doses for 48h or up to a week following major surgery 16
- Growth and development concerns, as well as bone health implications, should be considered when using prolonged steroid therapy in adolescents 3
- Close follow-up is necessary to assess response and manage any side effects of oral steroid therapy 3
- For prolonged treatments, measures for the prevention of corticosteroid-induced osteoporosis should be considered, as recommended by the National Osteoporosis Foundation 9
- The choice of corticosteroid and dose should be based on the severity of the disease, patient response, and side effect profile, with regular monitoring essential for adjusting the dose and minimizing adverse effects, according to the American College of Allergy, Asthma, and Immunology 17, 18
- Clinical response should be assessed after 2-4 weeks of initial high-dose therapy, and if improvement occurs, tapering should begin as outlined, according to the Mayo Clinic Proceedings 7
- For glomerulonephritis, the initial therapy is a daily single dose of prednisone 1 mg/kg (maximum 80 mg) or an alternate-day dose of 2 mg/kg (maximum 120 mg), with a minimum of 4 weeks of high-dose therapy if complete remission is achieved 6
- For systemic disease, large doses of prednisone may be limited to 6 months, with most patients requiring prednisone at some point and nearly half requiring maintenance treatment 19
- For critical manifestations of autoimmune disease, high-dose pulse therapy (1-10 mg/kg) may be used for disease flares, with low-medium doses (0.1-0.5 mg/kg/day) for maintenance 20